SCHEMBL6945778

SCHEMBL6945778

CCC(=O)Nc1ccc(N2N=C(C)CC2=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.56
KMT2A Q03164 5/20 0.56
MEN1 O00255 4/20 0.56
ALDH1A1 P00352 4/20 0.56
TDP1 Q9NUW8 4/20 0.56
HTT P42858 2/20 0.56
LMNA P02545 1/20 0.56
KDM4E B2RXH2 6/20 0.55
GAA P10253 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
CYP1A2 P05177 1/20 0.55
CHRM2 P08172 1/20 0.55
CYP3A4 P08684 1/20 0.55
CHRM1 P11229 1/20 0.55
TSHR P16473 1/20 0.55
PTGS1 P23219 1/20 0.55
DRD3 P35462 1/20 0.55
RECQL P46063 1/20 0.55
APP P05067 5/20 0.54
SMYD3 Q9H7B4 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8020214 0.85 KMT2A (0.66) MAPTKMT2AMEN1ALDH1A1TDP1
SCHEMBL8423947 0.84 KMT2A (0.60) MAPTKMT2AMEN1ALDH1A1TDP1
SCHEMBL8427633 0.84 ALDH1A1 (0.54) MAPTKMT2AMEN1ALDH1A1TDP1
SCHEMBL8424148 0.82 APP (0.58) MAPTKMT2AMEN1ALDH1A1TDP1
SCHEMBL4663160 0.80 MAPT (0.62) MAPTKMT2AMEN1ALDH1A1TDP1
SCHEMBL8428074 0.80 GAA (0.59) MAPTKMT2AMEN1ALDH1A1TDP1
SCHEMBL13122202 0.80 NPC1 (0.59) MAPTKMT2AMEN1ALDH1A1TDP1
SCHEMBL4661859 0.77 MAPT (0.68) MAPTKMT2AMEN1ALDH1A1TDP1
SCHEMBL2203669 0.77 MAPT (0.77) MAPTKMT2AMEN1ALDH1A1TDP1
SCHEMBL179128 0.76 MAPT (0.66) MAPTKMT2AMEN1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
US-5869516-A 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-02-09 US disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed